Medication info

Zentaramine Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›8gL-Leucine›14gL-Lysine Acetate›14.8gL-Methionine›3.9gL-Phenylalanine›7gL-Threonine›5.7gL-Tryptophan›2gL-Valine›8gL-Arginine›10.5gL-Histidine›5gL-Alanine›8gL-Proline›5gL-Serine›3gGlycine›5.9gL-Glutamic Acid›1gL-Aspartic Acid›1gL-Cysteine›1gL-Tyrosine›0.5g
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
This injection is a colorless, transparent liquid in a glass vial with a rubber stopper for intravenous use.
Packaging
250mL/bottle
Approval status
Active

MFDS item code 199900224 · Notified 1999.07.30

Summary

Main use
Improvement of nutritional status (such as hypoproteinemia and the period before or after surgery)
Who uses it
Adults · Children
Adult dosage
○ Peripheral intravenous administration: -Adults: Slowly infuse 200~400 mL intravenously per dose. -Infusion rate: Based on 120 minutes per 200 mL, approximately 10 g of amino acids over 60 minutes is desirable for utilization by the body, ○ Central venous administration: Continuously infuse 400~800 mL per day into a central vein according to the hyperalimentation method. For efficient utilization by the body of amino acids in preparations that do not contain sugar, concomitant administration with a sugar-containing infusion solution is preferable. In elderly patients and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.
Children's dosage
Infuse slowly in children, elderly patients, and critically ill patients. In children, adjust the dose and infusion rate as appropriate.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional status (such as hypoproteinemia and the period before or after surgery)

  • Hypoproteinemia
  • malnutrition
View approved original text

Hypoproteinemia and malnutrition require amino acid supplementation, especially in conditions such as before and after surgery. This is used to improve nutritional status and assist recovery in cases where there is a deficiency of protein or a tendency for nutritional status to deteriorate.

Dosage and Administration

Adult dosage

○ Peripheral intravenous administration: -Adults: Slowly infuse 200~400 mL intravenously per dose. -Infusion rate: Based on 120 minutes per 200 mL, approximately 10 g of amino acids over 60 minutes is desirable for utilization by the body, ○ Central venous administration: Continuously infuse 400~800 mL per day into a central vein according to the hyperalimentation method. For efficient utilization by the body of amino acids in preparations that do not contain sugar, concomitant administration with a sugar-containing infusion solution is preferable. In elderly patients and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Children's dosage

Infuse slowly in children, elderly patients, and critically ill patients. In children, adjust the dose and infusion rate as appropriate.

Precautions

This medication must be used strictly under the guidance of a physician and should not be taken or discontinued arbitrarily. It should not be administered to patients with hepatic coma or those at risk, severe renal dysfunction, or certain metabolic disorders. Administration should also be avoided in patients with congestive heart failure, pulmonary edema, very low or absent urine output, and those with a history of myocardial infarction. Caution is required for patients with severe acidosis, congestive heart failure, or abnormal sodium or potassium levels, as well as those with impaired liver and renal function. This product contains sodium bisulfite, which may cause allergic reactions or asthma attacks, so special caution is necessary for asthmatic patients. During administration, adverse reactions such as rash, nausea, vomiting, cardiac symptoms, chills, fever, headache, and respiratory distress may occur; if symptoms arise, immediate consultation with healthcare professionals is advised. Rapid large volume administration may lead to metabolic acidosis or other serious complications, requiring vigilance. To maintain electrolyte balance in the blood, electrolyte status should be frequently monitored during large volume administration, and patients with diabetes should regularly check blood glucose levels. Awareness of possible interactions with other medications is important, particularly when used with tetracycline antibiotics. Safety in pregnant women has not been established, so administration should only occur when absolutely necessary and after consultation with healthcare professionals. When administering to children or elderly patients, adjustments to dosage and infusion rates may be necessary due to differing physiological functions, and blood ammonia levels should be monitored in children. Because this product contains electrolytes, rapid intravenous injection may lead to side effects; administration should be adjusted according to the patient’s temperature. Sterility should be meticulously maintained during the administration process, and the solution must not be used if discoloration or contamination occurs. For storage, do not open the packaging and do not use if the rubber stopper is damaged. This medication must be used according to the prescribed dosage and method, and any unusual symptoms should be reported to a healthcare provider immediately.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • fast heartbeat
  • increased blood pressure
  • acidosis
  • chills
  • fever
Show 26 more
  • headache
  • shortness of breath
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • loss of perception
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent the ingress of air or moisture, with a preferred temperature between 1 and 30 degrees Celsius for optimal preservation and to prevent deterioration.

Appearance and packaging

Appearance

This injection is a colorless, transparent liquid in a glass vial with a rubber stopper for intravenous use.

Package unit

250mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.